| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2010 | US20100190839 Telomere-Encoding Synthetic DNA Nanocircles, and Their Use for the Elongation of Telomere Repeats |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190837 5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom |
| 07/29/2010 | US20100190836 Compounds, Screens, and Methods of Treatment |
| 07/29/2010 | US20100190835 Pharmaceutical composition comprising aleglitazar |
| 07/29/2010 | US20100190834 Composition for ophtalmic disease associated with hypoxia or ischemia |
| 07/29/2010 | US20100190833 Pharmaceutical containing ppara agonist |
| 07/29/2010 | US20100190832 Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates |
| 07/29/2010 | US20100190831 Gpr120 receptor agonists and uses thereof |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190829 Renin inhibitors |
| 07/29/2010 | US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained |
| 07/29/2010 | US20100190826 Benzimidazole derivative |
| 07/29/2010 | US20100190825 Benzimidazoles which have activity at m1 receptor and their uses in medicine |
| 07/29/2010 | US20100190824 Novel Substituted Piperidones as HSP Inducers |
| 07/29/2010 | US20100190823 Therapeutic ((Bicylicheteroaryl)Imidazolyl) Methylheteroaryl Compounds |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190821 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors |
| 07/29/2010 | US20100190820 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 07/29/2010 | US20100190819 alpha-7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof |
| 07/29/2010 | US20100190818 Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives |
| 07/29/2010 | US20100190817 Large substituent, non-phenolic amine opioids |
| 07/29/2010 | US20100190816 Kinase inhibitors |
| 07/29/2010 | US20100190815 Hypertension-ameliorating agent |
| 07/29/2010 | US20100190814 Spiroindolinone derivative prodrugs |
| 07/29/2010 | US20100190813 Spiro [piperidine-4- 4' -thieno [3,2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 07/29/2010 | US20100190812 Nilotinib hcl crystalline forms |
| 07/29/2010 | US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 07/29/2010 | US20100190810 Composition and method for treatment of warts |
| 07/29/2010 | US20100190809 Combination formulations |
| 07/29/2010 | US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis |
| 07/29/2010 | US20100190807 CDKI Pathway inhibitors and uses thereof to regulate expression to TAU protein |
| 07/29/2010 | US20100190806 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 07/29/2010 | US20100190805 Preparation for the treatment of equine laminitis |
| 07/29/2010 | US20100190804 Macrocyclic compounds and their use as kinase inhibitors |
| 07/29/2010 | US20100190803 Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient |
| 07/29/2010 | US20100190802 Carboxamide compounds and methods for using the same |
| 07/29/2010 | US20100190801 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/29/2010 | US20100190800 Combinaton of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 07/29/2010 | US20100190799 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
| 07/29/2010 | US20100190798 Pharmaceutical composition comprising racemic aminopterin |
| 07/29/2010 | US20100190797 Crystalline polymophic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
| 07/29/2010 | US20100190796 Methods for identifying inhibitors of solute transporters |
| 07/29/2010 | US20100190793 Compositions for affecting weight loss |
| 07/29/2010 | US20100190792 Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 07/29/2010 | US20100190791 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners |
| 07/29/2010 | US20100190790 Sigma receptor inhibitors |
| 07/29/2010 | US20100190789 Piperidine/piperazine derivatives |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190787 Modulators of Mitotic Kinases |
| 07/29/2010 | US20100190786 Indolin-2-ones and aza-indolin-2-ones |
| 07/29/2010 | US20100190785 Method for the purification of mycophenolate mofetil |
| 07/29/2010 | US20100190784 Organic Compounds |
| 07/29/2010 | US20100190783 Triazolone derivatives |
| 07/29/2010 | US20100190782 Compounds and methods of use |
| 07/29/2010 | US20100190781 Sigma receptor inhibitors |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190779 Viral polymerase inhibitors |
| 07/29/2010 | US20100190778 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use |
| 07/29/2010 | US20100190777 Compounds and methods for kinase modulation, and indications therefor |
| 07/29/2010 | US20100190776 Thiazoline and Oxazoline Derivatives and Their Methods of Use |
| 07/29/2010 | US20100190775 Pyrimidodiazepinone derivative |
| 07/29/2010 | US20100190774 Inhibitors of c-met and uses thereof |
| 07/29/2010 | US20100190773 Anti-Cytokine Heterocyclic Compounds |
| 07/29/2010 | US20100190772 Substituted Azepine Derivatives As Serotonin Receptor Modulators |
| 07/29/2010 | US20100190771 Amino-heterocyclic compounds |
| 07/29/2010 | US20100190770 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 07/29/2010 | US20100190768 Novel fused pyrole derivative |
| 07/29/2010 | US20100190767 Compounds for the treatment of inflammatory diseases |
| 07/29/2010 | US20100190766 Antibacterial agents |
| 07/29/2010 | US20100190765 Dihydrodiazepines useful as inhibitors of protein kinases |
| 07/29/2010 | US20100190764 Novel compounds |
| 07/29/2010 | US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100190761 Diphenyl substituted alkanes |
| 07/29/2010 | US20100190760 Process for Making Crystals |
| 07/29/2010 | US20100190759 Nk 1 antagonists |
| 07/29/2010 | US20100190758 Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding |
| 07/29/2010 | US20100190757 Combination preparation for oral contreaception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| 07/29/2010 | US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 07/29/2010 | US20100190755 Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment |
| 07/29/2010 | US20100190754 Azolylmethylidenehydrazine derivative and use thereof |
| 07/29/2010 | US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases |
| 07/29/2010 | US20100190752 tapentadol and antiepileptic such as gabapentin; synergistic pain relief |
| 07/29/2010 | US20100190751 Novel combination of neramexane for treatment of nerordegeneratie disorders |
| 07/29/2010 | US20100190750 GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto |
| 07/29/2010 | US20100190749 Benzoxazole kinase inhibitors and methods of use |
| 07/29/2010 | US20100190748 Boron-containing small molecules |
| 07/29/2010 | US20100190747 Fused ring compound and use thereof |
| 07/29/2010 | US20100190746 Quinazolinones as potassium channel modulators |
| 07/29/2010 | US20100190745 Heterocyclic urea derivatives and methods of use thereof |
| 07/29/2010 | US20100190744 Compositions and methods of treating viral infections |
| 07/29/2010 | US20100190743 Method and Composition for Treatment of a Mucosal Tissue Disorder |
| 07/29/2010 | US20100190742 Cosmetic/pharmaceutical compositions comprising hyaluronic acid and administration thereof for reducing signs of aging |
| 07/29/2010 | US20100190741 Injectable cross-linked polymeric preparations and uses thereof |
| 07/29/2010 | US20100190739 Rapidly Dissolving Vitamin Formulation and Methods of Using the Same |
| 07/29/2010 | US20100190738 Use of Aalkylphophocholines in Combination with Antitumor Medication for the Treatment of Benign and Melignant Oncoses in Humans and Mammals |
| 07/29/2010 | US20100190737 Compositions comprising inosine and orotic acid and methods of use thereof for the treatment of certain heart conditions and enhancement of work capacity |
| 07/29/2010 | US20100190736 Morpholinyl anthracycline derivative combined with protein kinase inhibitors |